Abingdon Health Plc
ABDX.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | £5,335 | £3,094 | £3,725 | £2,410 |
| % Growth | 72.4% | -16.9% | 54.6% | – |
| Cost of Goods Sold | £3,124 | £2,177 | £1,465 | £1,132 |
| Gross Profit | £2,211 | £917 | £2,260 | £1,278 |
| % Margin | 41.4% | 29.6% | 60.7% | 53% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £6,109 | £1,605 | £2,342 | £2,728 |
| SG&A Expenses | £4,438 | £3,276 | £2,380 | £2,738 |
| Sales & Mktg Exp. | £0 | £33 | £38 | £10 |
| Other Operating Expenses | -£709 | £0 | £0 | -£66 |
| Operating Expenses | £3,729 | £3,276 | £2,380 | £2,672 |
| Operating Income | -£1,518 | -£2,359 | -£120 | -£1,253 |
| % Margin | -28.5% | -76.2% | -3.2% | -52% |
| Other Income/Exp. Net | £655 | -£274 | -£59 | £33 |
| Pre-Tax Income | -£863 | -£2,633 | -£179 | -£1,220 |
| Tax Expense | £31 | -£112 | -£113 | -£15 |
| Net Income | -£894 | -£2,521 | -£66 | -£1,205 |
| % Margin | -16.8% | -81.5% | -1.8% | -50% |
| EPS | -0.002 | -0.007 | -0 | -0.004 |
| % Growth | 66.2% | -3,450% | 95% | – |
| EPS Diluted | -0.002 | -0.007 | -0 | -0.004 |
| Weighted Avg Shares Out | 375,948 | 354,640 | 309,034 | 304,034 |
| Weighted Avg Shares Out Dil | 375,948 | 354,640 | 309,034 | 306,668 |
| Supplemental Information | – | – | – | – |
| Interest Income | £52 | £48 | £5 | £26 |
| Interest Expense | £47 | £40 | £23 | £34 |
| Depreciation & Amortization | £341 | £267 | £141 | £285 |
| EBITDA | -£475 | -£2,326 | £266 | -£901 |
| % Margin | -8.9% | -75.2% | 7.1% | -37.4% |